1. Kynurenine-2-oxoglutarate aminotransferase (isoenzyme 1) was purified to homogeneity from the liver, brain and small intestine of rats by the same procedure. The three enzyme preparations had nearly identical pH optima, substrate specificities and molecular weights. Isoenzyme 1 was active with 2-oxoglutarate but not with pyruvate as amino acceptor, and utilized a wide range of amino acids as amino donors. Amino acids were effective in the following order of activity: L-aspartate>L-tyrosine>L-phenylalanine> L-tryptophan > 5-hydroxy-L-tryptophan > L-kynurenine. The molecular weight was approximately 88000 as determined by sucrose-density-gradient centrifugation. The pH optimum was between 8.0 and 8.5. On the basis of substrate specificity, substrate inhibition, subcellular distribution and polyacrylamide-disc-gel electrophoresis, it is suggested that liver, brain and small intestinal kynurenine-2-oxoglutarate aminotransferase (isoenzyme 1) is identical with mitochondrial tyrosine-2-oxoglutarate aminotransferase and also with mitochondrial aspartate-2-oxoglutarate aminotransferase. 2. An additional kynurenine-2-oxoglutarate aminotransferase (isoenzyme 2) was purified from the liver. This enzyme was specific for 2-oxoglutarate and L-kynurenine. Sucrose-density-gradient centrifugation gave a molecular weight of approximately 100000. The pH optimum was between 6.0 and 6.5. This enzyme was not detected in the brain or small intestine.
It is well known that kynurenine-2-oxoglutarate aminotransferase (L-kynurenine-2-oxoglutarate aminotransferase (cyclizing), EC 2.6.1.7] is present in mammalian liver and kidney (Mason, 1954 (Mason, , 1957 Ogasawara et al., 1962; Ueno et al., 1963; Nakatani et al., 1974) . The enzyme catalyses the formation of kynurenate from kynurenine, and shows a greater preference for 2-oxoglutarate than for pyruvate and other amino acceptors. We have reported the presence of kynurenine-2-oxoglutarate aminotransferase activity in the small intestine Nakamura et al., 1973 ) and brain of rats (Minatogawa et al., 1973) . However, previous investigations of kynurenine-2-oxoglutarate aminotransferase have not involved extensive purification or detailed analysis of the enzymic properties. The present report describes the purification and characterization of kynurenine-2-oxoglutarate aminotransferases from the liver, brain and small intestine of rats.
Experimental Materials L-Kynurenine was prepared by ozonolysis of Ltryptophan by the method of Warnell & Berg (1954) . L-Tyrosine, L-phenylalanine, L-tryptophan and LVol. 151 aspartate were purchased from Tanabe Amino Acid Foundation, Osaka, Japan, and 2-oxoglutarate and pyridoxal 5'-phosphate from Nakarai Chemicals, Kyoto, Japan. 5-Hydroxy-L-tryptophan was obtained from Calbiochem, San Diego, Calif., U.S.A., and DEAE-cellulose and hydroxyapatite from Seikagaku Kogyo Co. Ltd., Tokyo, Japan. Sephadex C-25 and Sephadex G-100 were products from Pharmacia Fine Chemicals, Uppsala, Sweden. Analytical-grade Dowex AGI resin (X8; 200-400 mesh; Cl-form) was from Bio-Rad Laboratories, Richmond, Calif., U.S.A. The acetate form of Dowex 1 was prepared as described by Roy & Price (1959) . Other chemicals were of the purest quality available.
Methods
Enzyme assays. Enzyme assays were carried out at 370C.
Kynurenine-2-oxoglutarate aminotransferase was assayed by measuring the amount of kynurenate formed by the Dowex 1-column method Nakamura et al., 1973) . The reaction mixture contained, in a final volume of 0.8 ml, 20mM-L-kynurenine, 8 mM-2-oxoglutarate and 40pM-pyridoxal 5'-phosphate in 0. 1 M-potassium phosphate buffer, pH 8.0, with isoenzyme 1 or pH6.5 with isoenzyme 2. 2-Oxoglutarate was omitted from the blank. Enzyme activity was calculated from the linear parts of the progress curves. A unit of enzyme activity is defined as the amount of enzyme that catalyses the formation of 1 umol of kynurenate/h under the above conditions. Specific activity is defined as enzyme units per mg of protein.
Tyrosine, phenylalanine, tryptophan and 5-hydroxytryptophan aminotransferase assays were based on the arsenate-catalysed formation of aromatic 2-oxo acid-enol-borate complexes that show characteristic absorption spectra in the 300nm region (George et al., 1967; Oja, 1968) . The reaction mixtures contained, in a final volume of 0.8 ml, 6.5mM-L-amino acid, 8 mM-2-oxoglutarate and 40.uM-pyridoxal 5'-phosphate in 0.1 M-potassium phosphate buffer, pH 8.0.
Aspartate-2-oxoglutarate aminotransferase assay was based on the increase in extinction at 280nm resulting from the formation of oxaloacetate (Nisonoff & Barnes, 1962) . Incubation was carried out in a total volume of 3.0ml containing 0.1 Mpotassium phosphate buffer, pH 8.0, 6.5mM-Laspartate, 8 mM-2-oxoglutarate and 40pM-pyridoxal 5'-phosphate.
Protein determination. The protein content was determined by the biuret method (Gornall et al., 1949) in crude extracts or by the method of Lowry et al. (1951) in purified preparations with bovine serum albumin as the standard.
Polyacrylamide-disc-gel electrophoresis. Electrophoresis was carried out at 4°C for 90min with a current of 2mA/column by the following two methods. The purified enzyme (about 15jug) was applied in 20% (w/v) sucrose solution and protein was stained with Amido Black.
One method used a continuous 5 % (w/v) total acrylamide-gel column (0.Scmx8cm) containing 0.25% bisacrylamide by the method of Barisas (1974) . The running buffer was 0.025M-Tris-acetate buffer, pH6.0. Crystal Violet was used as a tracking dye. For enzyme assay immediately after electrophoresis the gels were cut into 2mm slices and these were added individually to the assay medium as enzyme source.
A second method used a continuous 7 % (w/v) total acrylamide-gel column (0.5cm x 8cm) containing 0.184% bisacrylamide by the original procedures of Davis (1964) . A Tris-glycine buffer, pH8.9 (11.Og of Tris and 14.4g of glycine per 1) was used as the running buffer and Bromophenol Blue as a tracking dye.
Sucrose-density-gradient centrifugation. Approximate molecular-weight determinations were made on sucrose gradients (5-20%, w/v) by the method of Martin & Ames (1961) . Centrifugation was carried out at 39000rev./min with a RP 50 swinging-bucket rotor in a Hitachi 65P (Hitachi, Tokyo, Japan) at 4°C for 15h. Fractions (3 drops) were collected by upward displacement of the centrifuge tube contents with a Mitsumi Gradienter SJ-1300UD (Mitsumi Scientific Industry Co., Tokyo, Japan). Bovine catalase was used as internal standard with an assumed S2o,w = 11.3 S.
Results
Separation of kynurenine-2-oxoglutarate aminotransferases by DEAE-cellulose chromatography Donryu strain male rats (60-80g) were killed by decapitation, and livers, brains and small intestines were removed. Six livers and 70 brains were rinsed with ice-cold 5mM-potassium phosphate buffer, pH7.5, and weighed. Small intestines (32) were cut longitudinally, washed with tap water and weighed. Each tissue was homogenized in a Waring blender for 2min with 2vol. of ice-cold 5mM-potassium phosphate buffer, pH7.5. After three cycles of freezing and thawing, each homogenate was centrifuged at 1000OOg for 30min and each resulting supernatant was diluted with 5mM-potassium phosphate buffer, pH7.5, to a total volume of340mi. Subsequent procedures were carried out at about 4°C. Each supernatant solution was applied to a separate column (5.5cm x 17cm) of DEAE-cellulose equilibrated with 5mM-potassium phosphate buffer, pH 7.5, and elution was performed with successive 500ml volumes of 5, 15 and 250mM-potassium phosphate buffer, pH7.5. The flow rate was adjusted to about 200ml/h. Fractions (20ml) were collected and monitored for kynurenine-2-oxoglutarate aminotransferase activity. DEAE-cellulose column separations are shown in Fig. 1 . Kynurenine aminotransferase activities of the liver, brain and small intestinal extracts appeared in the non-adsorbed fraction (the first effluent and 5mM buffer fraction). However, chromatography of the liver extract resulted in the appearance of additional kynurenine-2-oxoglutarate aminotransferase activity in the adsorbed fraction (15mM buffer fraction).
The non-adsorbed kynurenine aminotransferase is referred to hereafter as isoenzyme 1 and the adsorbed kynurenine aminotransferase as isoenzyme 2.
Purification of isoenzyme 1 from the liver, brain and small intestine Liver, brain and small intestinal isoenzyme 1 were purified to homogeneity by the same procedure. All procedures were carried out at 0-40C. Potassium phosphate buffer, pH7.5, containing 200.uM-pyridoxal intestinal extract on DEAE-cellulose The extract (340ml), (a) from six rat livers, (b) from 70 rat brains or (c) from 32 rat small intestines was applied to a column (5.5 cmx 17cm) of DEAE-cellulose and eluted as described in the text. The fraction size was 20ml. Fractions 18-42 were eluted by 5mM-potassium phosphate buffer, pH7.5, fractions 43-67 by 15mM-potassium phosphate buffer, pH7.5, and fractions 68-92 by 250 mM-potassium phosphate buffer, pH7.5. Kynurenine-2-oxoglutarate aminotransferase was assayed at pH8.0 by the method described in the Experimental section.
buffer. The column was eluted in sequence with 100ml portions of 5 and then 15 mm buffer. The flow rate was adjusted to 130ml/h and fractions (4ml) were collected. The eluate was assayed for isoenzyme 1 activity that appeared in the 15mM buffer fraction. Active fractions were pooled and concentrated in Diaflo ultrafiltration cells with a G-1OT membrane.
Hydroxyapatite chromatography. The concentrated enzyme solution was applied to a hydroxyapatite column (1.3cmx5cm) previously equilibrated with 15mM buffer. The column was washed in sequence with 50ml portions of 15 and 50mM buffer, and then isoenzyme 1 was eluted with 100mM buffer. The flow rate and fraction size were 90ml/h and 4ml respectively. The active fractions were pooled and concentrated by ultrafiltration.
Sephadex G-100 gel filtration. The concentrated enzyme solution was added to a column (2.5cmx 100cm) of Sephadex G-100 equilibrated with 50mM buffer. The column was eluted with the same buffer at a flow rate of 25 ml/h. The effluent was collected in 3.6ml fractions and monitored for enzyme activity. The active fractions were pooled and concentrated by ultrafiltration.
Results of typical purifications of isoenzyme 1 from the liver, brain and small intestine are shown in Tables 1, 2 and 3 respectively. Isoenzyme 1 was purified about 217-fold over the liver extract, 370-fold over the brain extract and 724-fold over the intestinal extract. Liver isoenzyme 1 activity especially was recovered in very low yield, owing to the removal of an additional liver kynurenine-2-oxoglutarate aminotransferase (isoenzyme 2) by DEAE-cellulose chromatography (Fig. 1) . All three enzyme preparations were of nearly identical specific activity, suggesting the homogeneity and identity of these enzyme preparations.
Heat treatment. Active DEAE-cellulose isoenzyme 1 fractions (Fig. 1) were pooled, brought rapidly to 60°C and maintained at this temperature, with constant stirring, for 15s, after which they were quickly chilled in a cold-water bath. The resulting precipitate was removed by centrifugation.
(NH4)2 SO4 fractionation. Solid (NH4)2 SO4 was added with gentle stirring to the supernatant from the previous step to 60% saturation. After being left for 30min, the precipitate was removed by centrifugation and discarded. (NH4)2 SO4 was added to the supernatant to 95% saturation, and the precipitate was collected by centrifugation after 30min. The precipitate was dissolved in a minimum volume of 5mM buffer and desalted by dialysis against the same buffer overnight.
CM-Sephadex C-25 chromatography. The nondiffusible solution was placed on a column (3.0cm x 30cm) of Sephadex C-25 equilibrated with 5mM Vol. 151 Purification ofliver isoenzyme 2 All procedures were carried out at 0-40C. Potassium phosphate buffer, pH 7.5, containing 200pM-pyridoxal 5'-phosphate was used throughout.
Heat treatment. Active DEAE-cellulose isoenzyme 2 fractions (Fig. 1) were pooled. The enzyme solution was brought rapidly to 60°C in the presence of 2-oxoglutarate and 200,uM-pyridoxal 5'-phosphate and maintained at this temperature, with constant stirring, for 30s, after which it was quickly chilled in a cold-water bath. After centrifugation, the resulting supernatant was concentrated by ultrafiltration and diluted with distilled water to adjust the buffer concentration to 5mM.
Second DEAE-cellulose chromatography. The concentrated enzyme solution from the previous step was applied to a column (2.5cmx 7cm) of DEAEcellulose equilibrated with 5mM buffer. After concentrated by ultrafiltration and diluted with distilled water to adjust the buffer concentration to 5mM. CM-Sephadex C-25 chromatography. The concentrated enzyme solution was added to a column (2.5cmx25cm) of Sephadex C-25 previously equilibrated with 5mM buffer. The enzyme was eluted with the same buffer at a flow rate of lOOml/h. The active fractions were pooled and concentrated by ultrafiltration.
Sephadex G-100 gel filtration. The concentrated enzyme solution was placed on a column (2.5cm x 100cm) of Sephadex G-100 previously equilibrated 1975 with 50mM buffer. The column was eluted with the same buffer at a flow rate of25 ml/h. Fractions (3.6 ml) were collected and assayed for isoenzyme 2 activity.
A typical purification procedure is shown in Table 4 . Purification was about 190-fold and yield about 16%.
Criteria ofpurity
On Sephadex G-100 columns (the last step of purification), the purified isoenzyme 1 from the liver, brain and small intestine was eluted as a single symmetrical peak with protein and kynurenine aminotransferase activity coincident. Sephadex G-100 gel filtration of the purified liver isoenzyme 2 gave a single symmetrical peak with protein and enzyme activity coincident.
The sedimentation pattern of isoenzyme 1 in a sucrose density gradient (for molecular-weight determinations) was a single activity peak for enzyme preparation from any of the three tissues. Also liver isoenzymes 2 yielded a single activity peak under the same conditions.
On polyacrylamide-disc-gel electrophoresis at pH 6.0 in 5 % (w/v) gels, the purified isoenzyme 1 from the liver, brain or small intestine moved toward the cathode with the same mobility as a single protein band, and this coincided with all the measured aminotransferase activities, i.e. kynurenine, tyrosine or aspartate with 2-oxoglutarate. The activity ratio of isoenzyme 1 towards these amino acids was unchanged after electrophoresis. On electrophoresis at pH8.3 in 5% gels isoenzyme I remained as a single protein band at the starting point, as did activities toward all three amino donors. Electrophoresis of purified liver isoenzyme 2 at pH8.9 in 7% (w/v) gel did not give a single protein band and kynurenine aminotransferase activity was found to move toward the anode.
Properties ofisoenzyme 1 and isoenzyme 2 Liver, brain and small intestinal isoenzyme 1 preparations had nearly identical pH optima and Vol. 151 pH optimum. The relationship between pH and the enzymic activity was studied and the results are presented in Fig. 2 . The purified isoenzyme 1 had a pH optimum between 8.0 and 8.5, and isoenzyme 2 between 6.0 and 6.5.
Determination of molecular weight. Sucrosedensity-gradient centrifugation gave molecular weights of about 88000 and 100000 for isoenzyme 1 Table 6 . Inhibition ofkynurenine-2-oxoglutarate aminotransferase (isoenzymes 1 and 2) by L-aspartate and aromatic L-amino acids L-Kynurenine concentration was 6.5mM. L-Aspartate and aromatic amino acids were 5mM and added to the preincubation medium along with the enzyme for 5min before the reaction was initiated with L-kynurenine. Isoenzyme 1 activity was assayed at pH8.0 and isoenzyme 2 activity at pH6.5 as described in the text.
Inhibition (Y.)
Kynurenine-2-oxoglutarate aminotransferase 1 Addition Aspartate Tyrosine Phenylalanine Small  Brain intestine Liver  96  93  95  78  60  76  62  63  69 and isoenzyme 2 respectively, with bovine catalase (s20.w = 11.3S) as internal standard. Substrate specificity. With L-kynurenine, L-tyrosine and L-phenylalanine, isoenzyme 1 of the liver, brain and small intestine was specific for 2-oxoglutarate as amino acceptor exhibiting no measurable activity with pyruvate. The relative initial velocities of isoenzyme 1 and isoenzyme 2 with various amino acids (6.5mM) were determined by using 2-oxoglutarate (5 mM) as amino acceptor. Results are summarized in Table 5 . Isoenzyme 1 utilized a wide range of amino acids. These amino acids were effective as amino donors in the following order ofactivity: L-asparate > L-tyrosine > L-phenylalanine > L-tryptophan > 5-hydroxy-L-tryptophan > L-kynurenine. These results suggest that isoenzyme 1 may be identical with tyrosine-2-oxoglutarate aminotransferase (tyrosineKynurenine-2-oxoglutarate aminotransferase2 Liver 0 2.0 1.9 2-oxoglutarate aminotransferase, EC 2.6.1.5) and also with aspartate aminotransferase (L-aspartate-2-oxoglutarate aminotransferase, EC 2.6.1. 1). Further evidence was obtained with the addition of 5mM each of L-aspartate and various aromatic amino acids to the complete system of the isoenzyme 1 reaction. As shown in Table 6 , L-aspartate, L-tyrosine and Lphenylalanine all strongly inhibited the catalysis by isoenzyme 1 preparations from the liver, brain and small intestine on transamination between kynurenine and 2-oxoglutarate.
Liver isoenzyme 2 was specific for 2-oxoglutarate as amino acceptor showing no activity with pyruvate. But it was also specific for L-kynurenine; little or no activity was observed with L-tyrosine, L-phenylalanine, L-tryptophan, 5-hydroxy-L-tryptophan and L-aspartate. 1975 Subcellular distribution of kynurenine-2-oxoglutarate aminotransferase activity Liver kynurenine-2-oxoglutarate aminotransferase. We have reported that 68.3% of kynurenine-2-oxoglutarate aminotransferase was in the mitochondrial fraction and 12.3% in the supernatant fraction (Nakatani et al., 1974) . The supernatant fraction was prepared from 5g of rat liver by the method of de Duve et al. (1955) and was applied to a column (2.5 cmx 5cm) of DEAE-cellulose equilibrated with 5mM-potassium phosphate buffer, pH7.5. When elution was performed with successive 50ml volumes of 5, 15, 50 and 250mM of the same buffer, kynurenine-2-oxoglutarate aminotransferase activity was detected in the adsorbed isoenzyme 2 (15mM buffer) fraction but not in the non-adsorbed isoenzyme 1 (first effluent and 5mM buffer) fraction.
Brain kynurenine-2-oxoglutarate aminotransferase. Subcellular fractionation of rat brain was carried out by the method of Lapetina et al. (1967) . The distribution of the enzyme activity was as follows: nuclear fraction, 13.9%; crude mitochondrial fraction, 79.4%; microsomal fraction, 1.7%; supernatant fraction, 2.1 %. The total recovery of kynurenine-2-oxoglutarate aminotransferase was 97.1 %. The distribution of the enzyme corresponded well with that of brain tyrosine-2-oxoglutarate aminotransferase activity described by Miller & Litwack (1969) .
Small intestinal kynurenine-2-oxoglutarate aminotransferase. Subcellular fractionation of rat small intestine was performed as described by Noguchi et al. (1970) . The distribution was as follows: nuclear fraction, 34.9%; mitochondrial fraction, 54.7%; microsomal fraction, 0%; supernatant fraction, 3.1 %. The total recovery of kynurenine-2-oxoglutarate aminotransferase activity was 92.7 %. This distribution corresponded well to that of monoamine oxidase [amine-oxygen oxidoreductase (deaminating) (filavin-containing), EC 1.4.3.4] described by Noguchi et al. (1970) .
The results suggest that isoenzyme 1 is localized largely in the mitochondrial fraction of the liver, brain and small intestine.
Discussion
Mammalian liver and kidney kynurenine-2-oxoglutarate aminotransferases show a greater preference for 2-oxoglutarate than for pyruvate or other amino acceptors, and have a pH optimum near 6.0 (Mason, 1954 (Mason, , 1957 Ogasawara et al., 1962; Ueno et al., 1963; Okamoto & Hayaishi, 1970; Nakatani et al., 1974) . Recently our group reported the presence of kynurenine-2-oxoglutarate aminotransferase activity in the brain (Minatogawa et al., 1973) and small intestine Nakamura et al., 1973) of rats with a pH optimum Vol. 151 near 8.0. In the present study, kynurenine-2-oxoglutarate aminotransferase (isoenzyme 1) with a pH optimum between 8.0 and 8.5 was purified to homogeneity and characterized from the brain, small intestine and liver of rats. This enzyme was active with 2-oxoglutarate but not with pyruvate; it utilized a wide range of amino acids as amino donors. All the amino acids tested donated their amino group more effectively than kynurenine, and aspartate was the most effective. Miller & Litwack (1971) demonstrated that hepatic mitochondrial tyrosine-2-oxoglutarate aminotransferase was identical with hepatic mitochondrial asparate-2-oxoglutarate aminotransferase. Subsequently, Rosenberg et al. (1974) reported that heart tyrosine-2-oxoglutarate aminotransferase and hepatic mitochondrial aspartate-2-oxoglutarate aminotransferase were similar with regard to kinetics and specificity. Isoenzyme 1 showed a similar substrate specificity and molecular weight (approx. 90000) to the hepatic mitochondrial asparate-2-oxoglutarate aminotransferase described by Miller & Litwack (1971) .
On the basis of our observations on substrate specificity, substrate inhibition, polyacrylamide-gel electrophoresis, subcellular distribution and the report by Miller & Litwack (1971) , it is suggested that isoenzyme 1 is identical with mitochondrial tyrosine-2-oxoglutarate aminotransferase and also with mitochondrial aspartate-2-oxoglutarate aminotransferase.
Moreover we have applied the isoelectric-focusing technique with mitochondrial extracts of rat liver, brain and small intestine and detected a single aspartate-2-oxoglutarate aminotransferase activity peak with isoelectric point at pH9.4 that has also kynurenine-and tyrosine-2-oxoglutarate aminotransferase activities; and isoenzyme 1 from these tissues purified in the present study in each case has the same isoelectric point (unpublished work) . This observation and the present data suggest that isoenzyme 1 is the major mitochondrial aspartate-2-oxoglutarate aminotransferase of the liver, brain and small intestine.
On the other hand, an additional kynurenine-2-oxoglutarate aminotransferase (isoenzyme 2) with a pH optimum between 6.0 and 6.5 was purified and characterized from the liver in the present study. Isoenzyme 2 is specific for 2-oxoglutarate and kynurenine, and in other respects also shows different properties from isoenzyme 1. On the basis of pH optimum and substrate specificity, isoenzyme 2 appears to be identical with kynurenine-2-oxoglutarate aminotransferase previously described in mammalian liver and kidney. DEAE-cellulose chromatography (Fig. 1) indicates that the brain and small intestinal concentration of isoenzyme 2 is very small or zero. Our present data suggest the need to r. NOGtCHI AND OTHERS investigate the iole of asgpartate-2-oxoglutarate aminotransferase in tryptophan metabolist of brain and small intestine.
